Literature DB >> 404321

Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.

S M Krane, F G Kantrowitz, M Byrne, S R Pinnell, F R Singer.   

Abstract

Urimary excretion of hydroxyprolin (Hyp) is one index of total collagen degradation, from all sources. Since some of the Hyp released from collagen may be further metabolized before it is excreted, other markers are necessary to measure collagen breakdown. Excretion of the glycosides of hydroxylysine (Hyl), glucosyl galactosyl hydroxylysine (Hy1[Gl)cGa1]), and galactosyl hydroxylysine (Hyl[Ga)]), more accurately reflects collagen metabolism since these products occur in specificratios in different tissue collagens and are themselves metabolized only to a minor degree. The ratios of total Hy1/Hyp and Hyl(GlcGal)/Hyl(Ga1) were measured in the urine of norma. subjects and of patients with Paget's disease of bone, hyperphosphatasia, and extensive thermal burns. In patients with extensive thermal burns the pattern of urinary Hy1 and its glycosides was consistent with degradation of collagen in dermis and fascia. When bone collagen degradation was dominant, the pattern of urinary metabolites reflected that source. Pagetic bone collagen has an amino acid composition similar to normal bone and Hy1(G1cGa1/Hyl(G1) of 0.396-0.743,vs. normal of 0.474+/-0.088. In untreated patients with severe Paget's disease of bone or hyperphosphatasia (urinary Hyp greater than 2.0 micronmol/mg creatinine) urinary Hyl/Hyp averaged 0.052+/-0.042 (0.042+/-0.009 in normal bone) and Hy1(G1cGa1)/Hy1(Ga1) 0.601+/-0.017 (0.47+/-0.009 in normal bone). When bone resorption was decreased sufficiently with calcitonin or disodium etidronate in these patients, both the urinary ratios of Hy1/Hyp and Hy1(G1cGa1)/Hyl(Gal) rose. In normal subjects treated with calcitonin and excreting relatively little Hyp, the ratio of Hy1/H)P approached 0.7 and Hy1(G1ycGa1)/Hy1(Ga1) approached 3.5. There increased ratios reveal the existence of a source of collagen breakdown other than skin or bone. The first subcompoent of complement, Clq, which has collagen-like sequences, relatively high amounts of Hy1, and most of the glycosylated Hy1 as Hy1(G1cGa1), could be the source of these metabolites.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404321      PMCID: PMC372290          DOI: 10.1172/JCI108704

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  HYDROXYPROLINEMIA. II. A RARE METABOLIC DISEASE DUE TO A DEFICIENCY OF THE ENZYME "HYDROXYPROLINE OXIDASE".

Authors:  M L EFRON; E M BIXBY; C V PRYLES
Journal:  N Engl J Med       Date:  1965-06-24       Impact factor: 91.245

2.  Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involution.

Authors:  J F WOESSNER
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

3.  Quantitative and qualitative data on the pigment cells of adult human epidermis.

Authors:  R J STARICCO; H PINKUS
Journal:  J Invest Dermatol       Date:  1957-01       Impact factor: 8.551

4.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

5.  A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement).

Authors:  K B Reid
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

6.  Chemical studies of Clq; a modulator of immunoglobulin biology.

Authors:  K Yonemasu; R M Stroud; W Niedermeier; W T Butler
Journal:  Biochem Biophys Res Commun       Date:  1971-06-18       Impact factor: 3.575

7.  Diphosphonates and Page's disease of bone.

Authors:  R Smith; R G Russell; M Bishop
Journal:  Lancet       Date:  1971-05-08       Impact factor: 79.321

8.  Rheumatic manifestations of Paget's disease of bone.

Authors:  W A Franck; N M Bress; F R Singer; S M Krane
Journal:  Am J Med       Date:  1974-05       Impact factor: 4.965

9.  Degradation of 5-hydroxylysine in the rat and in the perfused liver.

Authors:  R H Hammerstedt; P B Swan; L M Henderson
Journal:  Arch Biochem Biophys       Date:  1968-10       Impact factor: 4.013

10.  Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine.

Authors:  Y Kakimoto; S Akazawa
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

View more
  13 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients.

Authors:  Mai Yamamoto; Maria Ines Pinto-Sanchez; Premysl Bercik; Philip Britz-McKibbin
Journal:  Metabolomics       Date:  2019-05-20       Impact factor: 4.290

3.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

4.  5-Hydroxy-L-lysine excretion in cystinuria.

Authors:  R A Roesel; P R Blankenship; V Ganapathy; F H Leibach
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Concentrations of CTX I, CTX II, DPD, and PYD in the urine as a biomarker for the diagnosis of temporomandibular joint osteoarthritis: A preliminary study.

Authors:  Soo-Min Ok; Seung-Min Lee; Hae Ryoun Park; Sung-Hee Jeong; Ching-Chang Ko; Yong-Il Kim
Journal:  Cranio       Date:  2017-08-07       Impact factor: 2.020

6.  Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.

Authors:  R Marabini; P Sirtori; R Chionna; L Barzizza; A Rubinacci
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

7.  Effect of an oral calcium load on urinary markers of collagen breakdown.

Authors:  A Rubinacci; P Divieti; R M Polo; M Zampino; G Resmini; R Tenni
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 8.  New developments in biochemical markers for osteoporosis.

Authors:  P Garnero; P D Delmas
Journal:  Calcif Tissue Int       Date:  1996       Impact factor: 4.333

9.  Bone biochemical markers for assessment of bone responses to differentiated phosphorus supply in growing-finishing pigs.

Authors:  Kristina U Sørensen; Marlena C Kruger; Jens Hansen-Møller; Hanne D Poulsen
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

10.  Urinary beta-1-galactosyl-0-hydroxylysine (GH) as a marker of collagen turnover of bone.

Authors:  L Moro; R S Pozzi Mucelli; C Gazzarrini; C Modricky; F Marotti; B de Bernard
Journal:  Calcif Tissue Int       Date:  1988-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.